C16orf82

Across TCGA pan-cancer cohorts, C16orf82 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of C16orf82’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where C16orf82 RNA is repressed in tumor relative to normal tissue. In most cancer types C16orf82 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BRCA and BLCA are the cancer types where C16orf82 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in C16orf82 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	−0.036	<.001	6	view →
BLCA	Female	All	+0.037	.046	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

C16orf82–BRCA

Open the BRCA breakdown →